General keynote: Clinical trial design

被引：3

作者：

Berry, DA ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

关键词：

D O I：

10.1006/gyno.2002.6951

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：S114 / S116

页数：3

共 5 条

[1] [Anonymous], 1996, BAYESIAN BIOSTATISTI
[2] A CASE FOR BAYESIANISM IN CLINICAL-TRIALS
BERRY, DA
[J]. STATISTICS IN MEDICINE, 1993, 12 (15-16) : 1377 - 1393
[3] Berry DA, 1996, STAT BAYESIAN PERSPE
[4] PETERS W, 1999, P AN M AM SOC CLIN, V18, P21
[5] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER
PETERS, WP
ROSS, M
VREDENBURGH, JJ
MEISENBERG, B
MARKS, LB
WINER, E
KURTZBERG, J
BAST, RC
JONES, R
SHPALL, E
WU, K
ROSNER, G
GILBERT, C
MATHIAS, B
CONIGLIO, D
PETROS, W
HENDERSON, IC
NORTON, L
WEISS, RB
BUDMAN, D
HURD, D
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1132 - 1143